Homonymous visual field defects and stroke in an older population

Stroke

Volumn 33, Issue 10, 2002, Pages 2417-2420

  Singh Gilhotra, Jagjit ^a,b   Mitchell, Paul ^a,b   Healey, Paul R ^a,b   Cumming, Robert G ^a   Currie, Jon ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Blindness; Epidemiology; Prevalence; Stroke assessment; Stroke outcome; Visual disorders; Visual fields

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRIVING ABILITY; FEMALE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STROKE; URBAN POPULATION; VISION TEST; VISUAL FIELD; VISUAL FIELD DEFECT;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUSTRALIA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SCOTOMA; SEX DISTRIBUTION; URBAN POPULATION; VISION TESTS; VISUAL FIELDS;

EID: 0036792817     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.str.0000037647.10414.d2     Document Type: Article

References (29)

1. Warlow CP. Epidemiology of stroke. Lancet. 1998;352(suppl 3):SIII1-SIII4.
2. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet. 1987;2:1196-1200.
3. Stewart DG. Stroke rehabilitation. 1: epidemiologic aspects and acute management. Arch Phys Med Rehabil. 1999;80(5 suppl 1):S4-S7.
4. Hankey GJ. Stroke: how large a public health problem, and how can the neurologist help? Arch Neurol. 1999;56:748-754.
5. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust. 1993;158:80-84.
6. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-344.
7. Bonita R, Solomon N, Broad JB. Prevalence of stroke and stroke-related disability: estimates from the Auckland Stroke Studies. Stroke. 1997;28:1898-1902.
8. Jongbloed L. Prediction of function after stroke: a critical review. Stroke. 1986;17:765-776.
9. Dombovy ML, Sandok BA, Basford JR. Rehabilitation for stroke: a review. Stroke. 1986;17:363-369.
10. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103:357-364.
11. Bots ML, Looman SJ, Koudstaal PJ, Hofman A, Hoes AW, Grobbee DE. Prevalence of stroke in the general population: the Rotterdam Study. Stroke. 1996;27:1499-1501.
12. O'Mahony PG, Thomson RG, Dobson R, Rodgers H, James OF. The prevalence of stroke and associated disability. J Public Health Med. 1999;21:166-171.
13. Geddes JM, Fear J, Tennant A, Picketing A, Hillman M, Chamberlain MA. Prevalence of self reported stroke in a population in northern England. J Epidemiol Commun Health. 1996;50:140-143.
14. Taylor HR, Livingston PM, Stanislavsky YL, McCarty CA. Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. Am J Ophthalmol. 1997;123:328-337.
15. O'Mahony PG, Dobson R, Rodgers H, James OF, Thomson RG. Validation of a population screening questionnaire to assess prevalence of stroke. Stroke. 1995;26:1334-1337.
16. Ward G, Jamrozik K, Stewart-Wynne E. Incidence and outcome of cerebrovascular disease in Perth, Western Australia. Stroke. 1988;19:1501-1506.
17. Di Carlo A, Candelise L, Gandolfo C, Grigoletto F, Volonnino G, Baldereschi M, Maggi S, Scarlato G, Amaducci L, Inzitari D. Influence of different screening procedures on the stroke prevalence estimates: the Italian Longitudinal Study on Aging. Cerebrovasc Dis. 1999;9:231-237.
18. Wong AM, Sharpe JA. A comparison of tangent screen, Goldmann, and Humphrey perimetry in the detection and localization of occipital lesions. Ophthalmology. 2000;107:527-544.
19. Kudma GR, Stanley MA, Remington LA. Pupillary dilation and its effects on automated perimetry results. J Am Optom Assoc. 1995;66:675-680.
20. Trobe JD, Lorber ML, Schlezinger NS. Isolated homonymous hemianopia: a review of 104 cases. Arch Ophthalmol. 1973;89:377-381.
21. Lawton Smith J. Homonymous hemianopia. Am J Ophthalmol. 1962;54:616-623.
22. Fujino T, Kigazawa K, Yamada R. Homonymous hemianopia: a retrospective study of 140 cases. Neuro-Ophthalmology. 1986;6:17-21.
23. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS). Natural History Study and Clinical Trial: design implications. AREDS Report No 1. Control Clin Trials. 1999;20:573-600.
24. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308:81-106.
25. Barker WH, Mullooly JP. Stroke in a defined elderly population, 1967-1985: a less lethal and disabling but no less common disease. Stroke. 1997;28:284-290.
26. Szlyk JP, Brigell M, Seiple W. Effects of age and hemianopic visual field loss on driving. Optom Vis Sci. 1993;70:1031-1037.
27. Thompson DW, Furlan AJ. Clinical epidemiology of stroke. Neurol Clin. 1996;14:309-315.
28. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86, 1: methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry. 1988;51:1373-1380.
29. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.